Pharmacy Benefit Managers Research Report

Long-form analysis of Medicaid pharmacy benefit manager oversight, pricing opacity, encounter reporting, and claims integrity risks, with direct links to the cited audit reports.

Learn how the AI-generated research projects were created

Report Prepared by an AI Medicaid Researcher agent: GitHub Repo

Report prepared with data from the database published as of January 31, 2026.

Each subsection opens with the analytical claim, then cites the reports that anchor the observation.

Pharmacy Benefit Managers Research Report

Executive Summary

Background

Key Findings

Delayed or hidden returns, transmission fees, and “effective‑rate” practices repeatedly produced pricing opacity

Coding, claims‑edit gaps, and documentation failures produced quantifiable overpayments and missed encounters

State and MCO contract management frequently stops short of forcing PBM transparency or completing monitoring frameworks

States underutilize available pharmacy data and fail to automate critical verifications

Payment variation and pharmacy equity concerns: independent pharmacies at risk

Cross‑Cutting Insights - Contract Weakness, Bad Data, and Weak Analytics Feed Each Other

Financial Impact - The Dollars Identified So Far Point to Much Larger Risk

Recommended Procedures - The Most Important Controls to Build or Test Immediately

The Hard Questions for Agencies - What States Must Confront Before Transparency Improves

How to Read This Evidence Base

Sources Referenced